Clinical proteomics: A need to define the field and to begin to set adequate standards

被引:237
作者
Mischak, Harald [1 ]
Apweiler, Rolf [1 ]
Banks, Rosamonde E. [1 ]
Conaway, Mark [1 ]
Coon, Joshua [1 ]
Dominiczak, Anna [1 ]
Ehrich, Jochen H. H. [1 ]
Fliser, Danilo [1 ]
Girolami, Mark [1 ]
Hermjakob, Henning [1 ]
Hochstrasser, Denis [1 ]
Jankowski, Joachim [1 ]
Julian, Bruce A. [1 ]
Kolch, Walter [1 ]
Massy, Ziad A. [1 ]
Neusuess, Christian [1 ]
Novak, Jan [1 ]
Peter, Karlheinz [1 ]
Rossing, Kasper [1 ]
Schanstra, Joost [1 ]
Semmes, O. John [1 ]
Theodorescu, Dan [1 ]
Thongboonkerd, Visith [1 ]
Weissinger, Eva M. [1 ]
Van Eyk, Jennifer E. [1 ]
Yamamoto, Tadashi [1 ]
机构
[1] Mosaiques Diagnost & Therapeut, D-30625 Hannover, Germany
关键词
biomarker; clinical diagnostics; protein marker discovery; protein profiling; proteome analysis;
D O I
10.1002/prca.200600771
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state-of-the-art, both in diagnosis and in therapy of diseases.
引用
收藏
页码:148 / 156
页数:9
相关论文
共 30 条
[1]   AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[2]  
[Anonymous], 1996, J Clin Oncol, V14, P671
[3]   The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer [J].
Baker, SG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (07) :511-515
[4]   Evaluating markers for the early detection of cancer: overview of study designs and methods [J].
Baker, SG ;
Kramer, BS ;
McIntosh, M ;
Patterson, BH ;
Shyr, Y ;
Skates, S .
CLINICAL TRIALS, 2006, 3 (01) :43-56
[5]   Reporting protein identification data - The next generation of guidelines [J].
Bradshaw, RA ;
Burlingame, AL ;
Carr, S ;
Aebersold, R .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (05) :787-788
[6]   Repetitive fragmentation products of albumin and α1-antitrypsin in glomerular diseases associated with nephrotic syndrome [J].
Candiano, Giovanni ;
Musante, Luca ;
Bruschi, Maurizio ;
Petretto, Andrea ;
Santucci, Laura ;
Del Boccio, Piero ;
Pavone, Barbara ;
Perfumo, Francesco ;
Urbani, Andrea ;
Scolari, Francesco ;
Ghiggeri, Gian Marco .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (11) :3139-3148
[7]   Protein identification using sequential ion/ion reactions and tandem mass spectrometry [J].
Coon, JJ ;
Ueberheide, B ;
Syka, JEP ;
Dryhurst, DD ;
Ausio, J ;
Shabanowitz, J ;
Hunt, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (27) :9463-9468
[8]   Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis [J].
Decramer, S ;
Wittke, S ;
Mischak, H ;
Zürbig, P ;
Walden, M ;
Bouissou, F ;
Bascands, JL ;
Schanstra, JP .
NATURE MEDICINE, 2006, 12 (04) :398-400
[9]   Prostate-specific antigen:: A review of the validation of the most commonly used cancer biomarker [J].
Hernández, J ;
Thompson, IM .
CANCER, 2004, 101 (05) :894-904
[10]   A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes [J].
Lapolla, A ;
Tubaro, M ;
Fedele, D ;
Reitano, R ;
Aricò, NC ;
Ragazzi, E ;
Seraglia, R ;
Vogliardi, S ;
Traldi, P .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (02) :162-168